100 Questions & Answers About Myeloma
Jones & Bartlett Publishers, Dec 26, 2012 - Medical - 160 pages
EMPOWER YOURSELF! Whether you’re a newly diagnosed myeloma patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor’s and patient’s views, 100 Questions & Answers About Myeloma, Third Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a hematologist-oncologist specializing in myeloma treatment, and featuring “insider” advice from an actual patient, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abnormal agents allogeneic stem cell allogeneic transplant amyloidosis anemia antibody assess autologous stem cell autologous trans autologous transplant beneﬁcial beneﬁt blood cells blood counts blood or urine body body’s bone marrow bone pain bortezomib cancer catheter cause central venous catheter chemotherapy chromosomes clinical trial clots complete remission complications corticosteroids dexamethasone diﬂ‘erent dose drug ﬁnancial ﬁrst fractures GVHD high—dose hlestion immune system immunoglobulin infections Jim Huston’s comments kidney failure kyphoplasty lenalidomide levels light chain lytic lesions M—protein marrow transplant ment MGUS monoclonal multiple myeloma myeloma cells myeloma patients normal ofthe oncologist patients with myeloma performed peripheral blood peripheral neuropathy physician plasma cells plasmacytoma platelet potential procedure prognosis protein QlCStiOH regimen relapse response result risk second opinion serum side effects side eﬂ‘ects signiﬁcant signiﬁcantly sometimes speciﬁc spinal cord stage stem cell transplant symptoms thalidomide tion tissues treat myeloma treatment of myeloma unrelated donor usually vaccine Waldenstrom’s disease x—rays zoledronic acid